It is considered one of the main risk factors for the development of T2D, a metabolic disease characterized by insulin resistance and/or impaired secretion of this hormone, which leads to high blood glucose levels (Wysocki et al, 2024)
Compared with GLP-1 RAs, more participants receiving tirzepatide 15 mg discontinued treatment due to adverse events (OR 2.29 [95% CI 1.39, 3.75], I 2 0%), whereas no difference was evident for tirzepatide 5 mg and 10 mg (ESM Table 3)
Active Ingredients L-Arginine, L-Carnitine, Zinc, Multivitamins Pharmacological Classification Dietary Supplements - Energy and Performance Support Mechanism of Action L-Arginine improves blood flow, while L-Carnitine boosts fat metabolism into energy
Chorneys 3 Ps: Protein (2030g/meal) to protect lean mass and steady blood sugar Portion (balanced plates
Practice Pearls: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral drugs for type 2 diabetes that inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the release of insulin in response to a meal
